Phase 1b study of embrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma: Results from the ongoing KEYNOTE-013 trial Meeting Abstract
| Authors: | Zinzani, P. L.; Ribrag, V.; Moskowitz, C. H.; Michot, J. M.; Kuruvilla, J.; Balakumaran, A.; Zhang, Y.; Marinello, P.; Chlosta, S.; Gustafson, E.; Shipp, M. A.; Armand, P. |
| Abstract Title: | Phase 1b study of embrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma: Results from the ongoing KEYNOTE-013 trial |
| Meeting Title: | 58th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 128 |
| Issue: | 22 |
| Meeting Dates: | 2016 Dec 3-6 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2016-12-02 |
| Language: | English |
| ACCESSION: | WOS:000394446804025 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V128.22.619.619 |
| Notes: | Meeting Abstract: 619 -- Source: Wos |
